Rangeley Capital’s Mural Oncology MURA Stock Holding History

Rangeley Capital’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-305,000	Closed	-$631K	–	147
2025 Q3	$631K	Buy	305,000 +258,487	+556%	+$556K	0.55%	44
2025 Q2	$115K	Buy	+46,513	New	+$110K	0.14%	56

Rangeley Capital's MURA Position: Q4 2025 in Review

Rangeley Capital sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 305,000 shares — an estimated $631K sold.

Rangeley Capital first reported a position in MURA in Q2 2025 and held it in 2 quarters. The position peaked at $631K in Q3 2025. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Rangeley Capital reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Rangeley Capital sold 305,000 Mural Oncology shares in Q4 2025, an estimated $631K.
Rangeley Capital first reported a position in Mural Oncology in Q2 2025 and held it in 2 quarters.
Rangeley Capital's Mural Oncology position peaked at $631K in Q3 2025.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Rangeley Capital's 13F filing for Q4 2025, filed 17 Feb 2026.